National rectal cancer guidelines are updated periodically. In this symposium, we will address recent updates on the use of cDNA in rectal cancer surgery decision-making, the management of stage 1 rectal cancer, the broad use of total neoadjuvant therapy and caution about use of short-course radiotherapy, and the role of watch and wait for the rectal primary in patients with stage 4 rectal cancer.
Moderators: Radhika Smith, MD, and Jon Vogel, MD
Speakers: Ramy Behman, MD; Leonardo Bustamante Lopez, MD; Colleen Donahue, MD; John Monson, MD; and John (Jamie) Berry, MD
Credit Hours Available: 1 AMA PRA Category 1 Credit(s)™
Release Date: October 12, 2026
CME Expires: October 12, 2029
There's more to see -- the rest of this topic is available only to subscribers.